Quick Takeaways
- Richard Christopher has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $363,611.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Richard Christopher and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | Chief Executive Officer, Director | $363,611 | +$13,641 | +3.9% | 29 Jul 2025 |
| NVIV | INVIVO THERAPEUTICS HOLDINGS CORP. | Chief Financial Officer | 17 Nov 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|